The pharmacological treatment of urinary incontinence Page 1 BJU International (1999), 84,
923–947 REVIEW The pharmacological treatment of urinary incontinence K.-E …

OBJECTIVE: To determine whether oestrogen replacement will produce an improvement in
the quantity, or quality, of pelvic collagen in postmenopausal women. DESIGN: A …

OBJECTIVE: The arcus tendineous fasciae pelvis (ATFP) provides support to the anterior
vagina. The objective of this study was to determine the impact of menopause on the …

Objectives To assess the prevalence of and risk factors for urinary (UI) and fecal (FI)
incontinence in adults in long-term care (LTC) settings and in the community, the …

Objective To compare tissue markers of collagen metabolism in the uterosacral ligaments
with those in vaginal tissue in women with uterine prolapse. Design Prospective …

The aim of this study was to investigate the influence on the paraurethral connective tissue
of different sling materials used in incontinence surgery. Biopsies from the paraurethral …

Background. Genital prolapse is a common and handicapping form of pelvic floor
dysfunction. To explain its genesis as a result of endopelvic connective tissue weakness, the …

OBJECTIVE: To estimate the effect of hormone therapy on risk of stress and urge urinary
incontinence. METHODS: The Heart Estrogen/progestin Replacement Study was a …

Background. Genital prolapse is a debilitating manifestation of pelvic floor dysfunction. The
cause of this condition has not been elucidated. The purpose of this study was to determine …

Due to some severe side effects “classical” hormone replacement therapy (HRT) is currently
being challenged by a therapy with phytoestrogens. Particularly soy and red clover derived …